August 2022
1. SCHNEIDER LS
   The Safety of Pimavanserin for Parkinson's Disease and Efforts to Reduce Antipsychotics for People With Dementia.
   Am J Psychiatry. 2022;179:519-521.
   

   >> Share

   
   
2. KALIN NH
   Neurodevelopmental and Neurodegenerative Illnesses: Autism, Fragile X Syndrome, Parkinson's Disease, and Dementia.
   Am J Psychiatry. 2022;179:515-518.
   

   >> Share

   
   June 2022
3. MOSHOLDER AD, Ma Y, Akhtar S, Podskalny GD, et al
   Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries.
   Am J Psychiatry. 2022 Jun 15:appiajp21090876. doi: 10.1176/appi.ajp.21090876.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share